Abstract

Despite the favourable effects of antipsychotics on positive symptoms of schizophrenia, many patients continue to suffer from distressing symptoms. Additional benefits of cognitive behaviour therapy for psychosis (CBTp) have been reported for approximately 50% of such patients. Given the role of left hemisphere-based language processes in responsiveness to CBT for depression, and language pathway abnormalities in psychosis, this study examined whether pre-therapy brain activity during a verbal monitoring task predicts CBTp responsiveness in schizophrenia. Fifty-two outpatients, stable on antipsychotics with at least one persistent distressing positive symptom and wishing to receive CBTp adjunctive to their treatment-as-usual, and 20 healthy participants underwent fMRI during monitoring of self- and externally-generated (normal and distorted) speech. Subsequently, 26 patients received CBTp for 6–8 months adjunctive to their treatment-as-usual (CBTp + TAU, 20 completers), and 26 continued with their treatment-as-usual (TAU-alone, 18 completers). Symptoms were assessed (blindly) at entry and follow-up. The CBTp + TAU and TAU-alone groups had comparable demographic characteristics, performance and baseline symptoms. Only the CBTp + TAU group showed improved symptoms at follow-up. CBTp responsiveness was associated with (i) greater left inferior frontal gyrus (IFG) activity during accurate monitoring, especially of own voice, (ii) less inferior parietal deactivation with own, relative to others’, voice, and (iii) less medial prefrontal deactivation and greater thalamic and precuneus activation during monitoring of distorted, relative to undistorted, voices. CBTp + TAU patients, on average, displayed left IFG and thalamic hypo-activation (<healthy participants). The findings implicate language processing (IFG), attention (thalamus), insight and self-awareness (medial prefrontal and parietal cortices) in CBTp responsiveness in schizophrenia.

Highlights

  • The beneficial effects of antipsychotics on positive symptoms in acutely ill patients with schizophrenia (Kasper, 2006), most likely via their actions at dopamine receptors (Kapur and Remington, 2001; Guillin et al, 2007), are well established

  • The present study aimed to examine the neural predictors of responsiveness to cognitive behaviour therapy for psychosis (CBTp) in schizophrenia using functional magnetic resonance imaging during a task involving monitoring of selfand externally-generated speech (Johns et al, 2001; Fu et al, 2006; Kumari et al, 2008)

  • We studied a group of healthy participants, matched on average to age and sex of the patient group, to investigate whether specific activity changes associated with CBTp responsiveness represented hyper, hypo, or normal level of activity changes

Read more

Summary

Introduction

The beneficial effects of antipsychotics on positive symptoms in acutely ill patients with schizophrenia (Kasper, 2006), most likely via their actions at dopamine receptors (Kapur and Remington, 2001; Guillin et al, 2007), are well established. Consistent with the notion of additional benefits of CBTp to pharmacotherapy alone, a large number of randomised controlled trials (RCTs) have demonstrated that persistent positive symptoms, delusions, and general symptoms, such as anxiety and depression, are improved by CBTp in patients who fail to show adequate clinical response to antipsychotic therapy alone (Pilling et al, 2002; Zimmermann et al, 2005; Pfammatter et al, 2006; Wykes et al, 2008). A greater understanding of the mediators of CBTp response may help to increase its benefits for the patients

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call